EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPTBiotechnology
Healthcare
$2.99 +1.98%
+$0.26 today
- Market cap
- $250.69M
- Beta
- 1.75
- P/E (TTM)
- -4.2
- EPS (TTM)
- -$3.16
52W Low $7.94High $19.11
Volume 2.75M
Average 0.95M
Price history
EyePoint Pharmaceuticals, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-79.06%
Period high
$18.85
Period low
$2.99
Latest
$2.99
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Oct 7, 2026 | Oct 7, 2026 | |
| 8-K | Sep 10, 2026 | Sep 10, 2026 | |
| SC 13G | Sep 8, 2026 | Sep 8, 2026 | |
| 4 | Aug 24, 2026 | Aug 24, 2026 | |
| 4 | Aug 18, 2026 | Aug 18, 2026 | |
| 8-K | Aug 17, 2026 | Aug 17, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 12, 2026 | Aug 12, 2026 | |
| S-8 | Aug 5, 2026 | Aug 5, 2026 | |
| 8-K | Aug 5, 2026 | Aug 5, 2026 | |
| 10-Q | Aug 5, 2026 | Aug 5, 2026 | |
| SC 13G | Jul 31, 2026 | Jul 31, 2026 | |
| 8-K | Jul 30, 2026 | Jul 30, 2026 | |
| SC 13G/A | Jul 28, 2026 | Jul 28, 2026 | |
| 8-K | Jul 17, 2026 | Jul 17, 2026 |
Competitors
Who does EyePoint Pharmaceuticals, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about EYPT's filings, answered from its disclosures.
What is the latest EYPT filing?
The latest filing shown is SC 13G/A dated Oct 7, 2026.
How many recent filings does EYPT have?
Intrinsic Alpha currently shows 20 recent filings for EYPT.
Continue the stock analysis
Jump to another research area for this company.